sanofi nasdaq - Search News

News

Sanofi buys Vigil Neuroscience for $470m

Sanofi to buy Vigil Neuroscience in $470M deal (update)

Sanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (NASDAQ:VIGL) for $470M in cash, potentially reaching $600M with milestone payments. Following a trading halt,

Nasdaq · 3d

Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout

French pharma giant Sanofi SNY recently announced that it has agreed to acquire Massachusetts-based biotech Vigil Neuroscience VIGL for a total equity value of around $470 million. The acquisition ...

Insider Monkey on MSN · 3d

Sanofi Set to Acquire Vigil Neuroscience in $470 Million Deal

Sanofi (NASDAQ:SNY) has announced a deal to acquire Vigil Neuroscience, a clinical-stage biotech company, for around $470 million, aiming to strengthen its research pipeline with a potential new Alzheimer’s treatment.

Nasdaq3d

Sanofi To Acquire Vigil Neuroscience With Investigational Alzheimer's Drug VG-3927

On Wednesday, Sanofi closed its trading 0.02% higher at $52.90 on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those ...

23hon MSN

Key deals this week: Foxconn, Sanofi, Honeywell, Adriatic Metals, Informatica and more

Foxconn Technology (OTCPK:FXCOF) is among potential bidders for UTAC Holdings in a transaction that could value the Singapore-based semiconductor assembly and testing company at about $3 billion.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Sanofi buys Vigil Neuroscience for $470m

Trending now